Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18109
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Albert, J. M. | en |
dc.contributor.author | Ioannidis, J. P. | en |
dc.contributor.author | Reichelderfer, P. | en |
dc.contributor.author | Conway, B. | en |
dc.contributor.author | Coombs, R. W. | en |
dc.contributor.author | Crane, L. | en |
dc.contributor.author | Demasi, R. | en |
dc.contributor.author | Dixon, D. O. | en |
dc.contributor.author | Flandre, P. | en |
dc.contributor.author | Hughes, M. D. | en |
dc.contributor.author | Kalish, L. A. | en |
dc.contributor.author | Larntz, K. | en |
dc.contributor.author | Lin, D. | en |
dc.contributor.author | Marschner, I. C. | en |
dc.contributor.author | Munoz, A. | en |
dc.contributor.author | Murray, J. | en |
dc.contributor.author | Neaton, J. | en |
dc.contributor.author | Pettinelli, C. | en |
dc.contributor.author | Rida, W. | en |
dc.contributor.author | Taylor, J. M. | en |
dc.contributor.author | Welles, S. L. | en |
dc.date.accessioned | 2015-11-24T18:50:36Z | - |
dc.date.available | 2015-11-24T18:50:36Z | - |
dc.identifier.issn | 0277-6715 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18109 | - |
dc.rights | Default Licence | - |
dc.subject | *Biological Markers | en |
dc.subject | CD4 Lymphocyte Count | en |
dc.subject | Disease Progression | en |
dc.subject | HIV/genetics | en |
dc.subject | HIV Infections/*diagnosis/therapy | en |
dc.subject | Humans | en |
dc.subject | *Models, Statistical | en |
dc.subject | Proportional Hazards Models | en |
dc.subject | RNA, Viral/analysis | en |
dc.subject | Statistics as Topic | en |
dc.subject | Treatment Outcome | en |
dc.title | Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/9819838 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 1998 | - |
heal.abstract | This paper summarizes the proceedings of an NIAID-sponsored workshop on statistical issues for HIV surrogate endpoints. The workshop brought together statisticians and clinicians in an attempt to shed light on some unresolved issues in the use of HIV laboratory markers (such as HIV RNA and CD4+ cell counts) in the design and analysis of clinical studies and in patient management. Utilizing a debate format, the workshop explored a series of specific questions dealing with the relationship between markers and clinical endpoints, and the choice of endpoints and methods of analysis in clinical studies. This paper provides the position statements from the two debaters on each issue. Consensus conclusions, based on the presentations and discussion, are outlined. While not providing final answers, we hope that these discussions have helped clarify a number of issues, and will stimulate further consideration of some of the highlighted problems. These issues will be critical in the proper assessment and use of future therapies for HIV disease. | en |
heal.journalName | Stat Med | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License